Sun Pharma slides 4% after Co says forensic audit by Sebi underway

A forensic audit has been ordered by Sebi w.r.t. the financial statements of the company for the financial years ending FY16, FY17, and FY18.

Sun Pharma slipped 4 per cent to Rs 414.6 apiece on the BSE in the early morning trade on Friday after the drug-maker informed the exchanges about a forensic audit being undertaken by markets’ regulator Securities Exchange Board of India (Sebi).
 

“A forensic audit has been ordered by Sebi w.r.t. the financial statements of Sun Pharmaceutical Industries for the financial years ending FY16, FY17, and FY18,” the company said in a filing. CLICK HERE TO READ THE FILING
 

At 10:05 am, the stock was trading 3.88 per cent lower at Rs 415.20 per share, as against a 0.34 per